drugset / Trial / NCT07359248
Desvenlafaxine for Preventive Treatment of Frequent Episodic Tension-type Headache
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To evaluate whether Desvenlafaxine can reduce the frequency and severity of TTH attacks in patients.
Timeline
- Start
- 2025-12-01
- Primary completion
- 2027-12-31
- Completion
- 2028-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | Oral |
Indications
No indication recorded.